Mikaël Roussel

3.5k total citations
76 papers, 1.8k citations indexed

About

Mikaël Roussel is a scholar working on Immunology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Mikaël Roussel has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 27 papers in Pathology and Forensic Medicine and 17 papers in Hematology. Recurrent topics in Mikaël Roussel's work include Lymphoma Diagnosis and Treatment (21 papers), Immune cells in cancer (18 papers) and Immune Cell Function and Interaction (14 papers). Mikaël Roussel is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Immune cells in cancer (18 papers) and Immune Cell Function and Interaction (14 papers). Mikaël Roussel collaborates with scholars based in France, United States and Italy. Mikaël Roussel's co-authors include Thierry Fest, Karin Tarte, Céline Pangault, Arnaud Gacouin, Thierry Lamy, Yves Le Tulzo, Fabrice Uhel, Christophe Camus, Imane Azzaoui and Joëlle Dulong and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Mikaël Roussel

72 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikaël Roussel France 25 942 442 403 339 287 76 1.8k
Ran Reshef United States 27 635 0.7× 361 0.8× 995 2.5× 350 1.0× 171 0.6× 140 2.3k
John L. Reagan United States 20 453 0.5× 329 0.7× 580 1.4× 403 1.2× 172 0.6× 107 1.5k
Elizabeth Naparstek Israel 28 705 0.7× 368 0.8× 571 1.4× 335 1.0× 412 1.4× 98 2.3k
Sheila Gujrathi United States 17 563 0.6× 288 0.7× 189 0.5× 358 1.1× 113 0.4× 30 1.9k
H. Terence Cook United Kingdom 22 824 0.9× 249 0.6× 124 0.3× 370 1.1× 161 0.6× 45 2.3k
João L. Ascensão United States 21 282 0.3× 295 0.7× 529 1.3× 334 1.0× 342 1.2× 65 1.8k
Daniel J. Birmingham United States 28 1.4k 1.5× 137 0.3× 147 0.4× 341 1.0× 156 0.5× 66 2.4k
Sarfraz Memon United States 18 1.1k 1.2× 236 0.5× 611 1.5× 370 1.1× 99 0.3× 31 2.0k
Belinda R. Avalos United States 23 709 0.8× 91 0.2× 779 1.9× 387 1.1× 227 0.8× 100 2.1k
Tiffany Caza United States 23 667 0.7× 223 0.5× 215 0.5× 505 1.5× 131 0.5× 76 2.0k

Countries citing papers authored by Mikaël Roussel

Since Specialization
Citations

This map shows the geographic impact of Mikaël Roussel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikaël Roussel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikaël Roussel more than expected).

Fields of papers citing papers by Mikaël Roussel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikaël Roussel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikaël Roussel. The network helps show where Mikaël Roussel may publish in the future.

Co-authorship network of co-authors of Mikaël Roussel

This figure shows the co-authorship network connecting the top 25 collaborators of Mikaël Roussel. A scholar is included among the top collaborators of Mikaël Roussel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikaël Roussel. Mikaël Roussel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hémon, Patrice, et al.. (2025). Protocol for phenotyping mouse myeloid and lymphoid cells by mass cytometry. STAR Protocols. 6(1). 103684–103684.
2.
Pastoret, Cédric, Jun Yang, David J. Feith, et al.. (2025). Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study. Blood Advances. 10(3). 642–653.
3.
Desmots, Fabienne, Delphine Rossille, Mikaël Roussel, et al.. (2023). The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity. Clinical Cancer Research. 29(12). 2280–2290. 1 indexed citations
4.
Villar, Javiera, Renaud Leclère, Simon Le Gallou, et al.. (2023). Functional specialization of short-lived and long-lived macrophage subsets in human tonsils. The Journal of Experimental Medicine. 220(7). 3 indexed citations
5.
Robin, Fabien, Jonathan Chemouny, Camille Tron, et al.. (2022). Drug transporters are implicated in the diffusion of tacrolimus into the T lymphocyte in kidney and liver transplant recipients: Genetic, mRNA, protein expression, and functionality. Drug Metabolism and Pharmacokinetics. 47. 100473–100473. 2 indexed citations
6.
Pastoret, Cédric, Fabienne Desmots, Simon Le Gallou, et al.. (2021). Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells. Blood. 137(23). 3237–3250. 35 indexed citations
8.
Gallou, Simon Le, et al.. (2020). High-Dimensional Phenotyping of Human Myeloid-Derived Suppressor Cells/Tumor-Associated Macrophages in Tissue by Mass Cytometry. Methods in molecular biology. 2236. 57–66. 4 indexed citations
9.
Cassetta, Luca, Espen S. Bækkevold, Sven Brandau, et al.. (2019). Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates. Cancer Immunology Immunotherapy. 68(4). 687–697. 163 indexed citations
10.
Desmots, Fabienne, Mikaël Roussel, Céline Pangault, et al.. (2018). Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma. Clinical Cancer Research. 25(2). 735–746. 19 indexed citations
11.
Uhel, Fabrice, Imane Azzaoui, Murielle Grégoire, et al.. (2017). Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis. American Journal of Respiratory and Critical Care Medicine. 196(3). 315–327. 158 indexed citations
12.
Greenplate, Allison R., Douglas B. Johnson, Mikaël Roussel, et al.. (2016). Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti–PD-1 Therapy. Cancer Immunology Research. 4(6). 474–480. 16 indexed citations
13.
Azzaoui, Imane, Fabrice Uhel, Delphine Rossille, et al.. (2016). T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. Blood. 128(8). 1081–1092. 123 indexed citations
15.
Poullot, Elsa, Renato Zambello, Francis LeBlanc, et al.. (2014). Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Annals of Oncology. 25(10). 2030–2035. 45 indexed citations
17.
Pastoret, Cédric, Jérôme Le Priol, Thierry Fest, & Mikaël Roussel. (2012). Evaluation of FMH QuikQuant for the detection and quantification of fetomaternal hemorrhage. Cytometry Part B Clinical Cytometry. 84B(1). 37–43. 11 indexed citations
18.
Roussel, Mikaël, Bruce H. Davis, Thierry Fest, & Brent L. Wood. (2012). Toward a reference method for leukocyte differential counts in blood: Comparison of three flow cytometric candidate methods. Cytometry Part A. 81A(11). 973–982. 26 indexed citations
19.
Roussel, Mikaël, et al.. (2011). Cyclin D1 Inhibits Mitochondrial Activity in B Cells. Cancer Research. 71(5). 1690–1699. 31 indexed citations
20.
Roussel, Mikaël, Mathieu Nacher, Grégoire Martin de Frémont, et al.. (2006). Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Annals of Tropical Medicine and Parasitology. 100(4). 307–314. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026